Arvinas (ARVN) Amortizatization of Intangibles (2017 - 2026)

Arvinas' (ARVN) quarterly Amortizatization of Intangibles came in at $1.7 million in Q1 2026, down 55.26% year-on-year from $3.8 million in Q1 2025, and down 29.17% quarter-over-quarter from $2.4 million in Q4 2025.

Arvinas (ARVN) Amortizatization of Intangibles (2017 - 2026) Analysis & Trends

Arvinas' Amortizatization of Intangibles history runs 10 years deep, the most recent figure standing at $1.7 million for Q1 2026.

  • On a quarterly basis, Amortizatization of Intangibles fell 55.26% year-over-year to $1.7 million in Q1 2026; TTM through Mar 2026 was $10.7 million, a 46.77% decrease from a year earlier, with the FY2025 full-year figure at $12.8 million, down 41.28% from the prior year.
  • Amortizatization of Intangibles retreated to $1.7 million in Q1 2026 per ARVN's latest filing, from $2.4 million in the prior quarter.
  • Across five years, Amortizatization of Intangibles topped out at $5.9 million in Q3 2024 and bottomed at -$3.3 million in Q1 2022.
  • The 5-year median for Amortizatization of Intangibles is $3.5 million (2025), against an average of $2.8 million.
  • Across the five-year window, Amortizatization of Intangibles plunged 230.0% in 2022 and jumped 757.14% in 2023, its largest moves.
  • Year by year, Amortizatization of Intangibles stood at $800000.0 in 2022, then soared by 525.0% to $5.0 million in 2023, then decreased by 6.0% to $4.7 million in 2024, then slumped by 48.94% to $2.4 million in 2025, then fell by 29.17% to $1.7 million in 2026.
  • Per Business Quant, the three latest ARVN Amortizatization of Intangibles figures stand at $1.7 million (Q1 2026), $2.4 million (Q4 2025), and $3.1 million (Q3 2025).

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Amortizatization of Intangibles (Qtr)
1 Oculis Holding AG 66,621.14 Bn 66,620.85 Bn - -
2 Nanobiotix 1,915.18 Bn 1,915.11 Bn - -
3 Akari Therapeutics 1,014.18 Bn 1,014.18 Bn - -
4 BeOne Medicines 471.27 Bn 466.48 Bn 1.35 Bn -
5 Vertex Pharmaceuticals 121.81 Bn 114.57 Bn 2.59 Bn -
6 Regeneron Pharmaceuticals 69.58 Bn 60.82 Bn 3.31 Bn -
7 Belite Bio 62.72 Bn 62.72 Bn - -
8 Argenx Se 55.51 Bn 50.33 Bn 1.41 Bn -
9 Revolution Medicines 37.35 Bn 37.35 Bn - 3.22 Mn
10 Arvinas 529.92 Mn -84.98 Mn - 1.70 Mn

Historic Data

Download Data
DateValue
Mar 31, 2026 1.70 Mn
Mar 31, 2026 1.70 Mn
Dec 31, 2025 2.40 Mn
Dec 31, 2025 2.40 Mn
Sep 30, 2025 3.10 Mn
Sep 30, 2025 3.10 Mn
Jun 30, 2025 3.50 Mn
Jun 30, 2025 3.50 Mn
Mar 31, 2025 3.80 Mn
Mar 31, 2025 3.80 Mn
Dec 31, 2024 4.70 Mn
Dec 31, 2024 4.70 Mn
Sep 30, 2024 5.90 Mn
Sep 30, 2024 5.90 Mn
Jun 30, 2024 5.70 Mn
Jun 30, 2024 5.70 Mn
Mar 31, 2024 5.50 Mn
Mar 31, 2024 5.50 Mn
Dec 31, 2023 5.00 Mn
Dec 31, 2023 5.00 Mn